Mutant p53 protects cells from 12-O-tetradecanoylphorbol-13-acetate-induced death by attenuating activating transcription factor 3 induction

scientific article published on November 2006

Mutant p53 protects cells from 12-O-tetradecanoylphorbol-13-acetate-induced death by attenuating activating transcription factor 3 induction is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1158/0008-5472.CAN-06-0916
P698PubMed publication ID17108111

P50authorVarda RotterQ16131089
Ran BroshQ38327822
Michael MilyavskyQ73482970
Yosef BuganimQ88416666
Igor ShatsQ98280936
Naomi GoldfingerQ114537350
Yoach RaisQ114537361
Perry StambolskyQ114537362
P2093author name stringXiaohu Tang
Ido Nachmany
Eyal Kalo
Hila Besserglick
Marina Kalis
P2860cites workTransactivation of the EGR1 gene contributes to mutant p53 gain of functionQ38334166
P433issue22
P407language of work or nameEnglishQ1860
P304page(s)10750-10759
P577publication date2006-11-01
P1433published inCancer ResearchQ326097
P1476titleMutant p53 protects cells from 12-O-tetradecanoylphorbol-13-acetate-induced death by attenuating activating transcription factor 3 induction
P478volume66

Reverse relations

cites work (P2860)
Q41972847Activating Transcription Factor 3 regulates in part the enhanced tumour cell cytotoxicity of the histone deacetylase inhibitor M344 and cisplatin in combination
Q33762700Activating transcription factor-3 (ATF3) functions as a tumor suppressor in colon cancer and is up-regulated upon heat-shock protein 90 (Hsp90) inhibition
Q34009832Cisplatin induces cytotoxicity through the mitogen-activated protein kinase pathways and activating transcription factor 3.
Q42819037Differential effects of novel tumour-derived p53 mutations on the transformation of NIH-3T3 cells
Q33890980Dynamic expression patterns of ATF3 and p53 in the hippocampus of a pentylenetetrazole-induced kindling model
Q28077156Emerging Non-Canonical Functions and Regulation by p53: p53 and Stemness
Q91817209Gain-of-Function Mutant p53: All the Roads Lead to Tumorigenesis
Q38947220Mechanisms of resistance to apoptosis in the human acute promyelocytic leukemia cell line NB4.
Q24681272Mutant p53 attenuates the SMAD-dependent transforming growth factor beta1 (TGF-beta1) signaling pathway by repressing the expression of TGF-beta receptor type II
Q33687048Mutant p53 gain-of-function in cancer
Q38197826Mutant p53 in cancer: new functions and therapeutic opportunities
Q36293880Mutant p53-R273H mediates cancer cell survival and anoikis resistance through AKT-dependent suppression of BCL2-modifying factor (BMF).
Q38846785Oncogenic Mutant p53 Gain of Function Nourishes the Vicious Cycle of Tumor Development and Cancer Stem-Cell Formation
Q28570662Subcellular localization of Daxx determines its opposing functions in ischemic cell death
Q37691694The activating transcription factor 3 protein suppresses the oncogenic function of mutant p53 proteins
Q38198487The paradigm of mutant p53-expressing cancer stem cells and drug resistance
Q36777349Transcription regulation by mutant p53.
Q39005896Transcriptional Regulation by Wild-Type and Cancer-Related Mutant Forms of p53.
Q37582777When mutants gain new powers: news from the mutant p53 field.
Q45888635p53: balancing tumour suppression and implications for the clinic

Search more.